4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments
    Journal Article

    Naing, A.; Khalil, D.; Rosen, O.; Camidge, D. R.; Lillie, T.; Ji, R. R.; Stacey, A.; Thomas, M.; Rosen, L.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of ERBB2-altered gallbladder cancer: Exploring differences between an American and a Chilean cohort
    Journal Article

    Mondaca, S.; Walch, H.; Sepúlveda, S.; Schultz, N.; Muñoz, G.; Yaqubie, A.; Macanas, P.; Pareja, C.; Garcia, P.; Chatila, W.; more...
    JCO Global Oncology (2024)

    Fulltext@MSK | Save
  • Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings
    Research Letter

    Ceyhan-Birsoy, O.; Fiala, E.; Rana, S.; Sheehan, M.; Kennedy, J.; Yelskaya, Z.; Rai, V.; Li, Y.; Yang, C.; Wong, D.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Response to: Cholangiocarcinoma patients with FGFR2 fusions/rearrangements but primary refractory to pemigatinib: The real challenge?
    Correspondence

    Vogel, A.; Zhen, H.; Veronese, M. L.; Abou-Alfa, G. K.
    ESMO Open (2024)

    Fulltext@MSK | Save
  • Evaluating Debio 1347 in patients with FGFR fusion-positive advanced solid tumors from the FUZE multicenter, open-label, phase II basket trial
    Journal Article

    Grivas, P.; Garralda, E.; Meric-Bernstam, F.; Mellinghoff, I. K.; Goyal, L.; Harding, J. J.; Dees, E. C.; Bahleda, R.; Azad, N. S.; Karippot, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Chemotherapy switch for localized pancreatic cancer: A systematic review and meta-analysis
    Review

    Dekker, E. N.; Narayan, R. R.; Ahmami, M. A.; Meddouch, A.; Verkolf, E. M. M.; Gehrels, A. M.; Besselink, M. G. H.; van Eijck, C. H. J.; Homs, M. Y. V.; Mostert, B.; more...
    British Journal of Surgery (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of BRAF inhibitor plixorafenib (FORE8394; PLX8394) in children and adults with recurrent, BRAF-altered primary central nervous system tumors (PCNST)
    Meeting Abstract

    de la Fuente, M.; Butowski, N. A.; Taylor, J.; Yaeger, R.; Tsai, F. Y. C.; Janku, F.; Allen, C. E.; Ammakkanavar, N.; Michelson, G.; Jiang, P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Genomic profiling of bladder cancer in waterpipe and cigarette smokers: Implications for carcinogenicity and genetic landscape
    Meeting Abstract

    Shamseddine, A.; Abbas, N.; Chatila, W. K.; Walch, H. S.; Eichholz, J.; Schultz, N.; Solit, D. B.; Charafeddine, M.; Al Darazi, M.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1b/2 study to evaluate the safety and efficacy of TTI-101 as monotherapy and in combination in advanced hepatocellular carcinoma
    Meeting Abstract

    Dayyani, F.; Baretti, M.; Lee, S. S.; He, A. R.; Kim, R. D.; Lin, B. S. L.; Enzler, T.; Al Hallak, M. N.; Ulahannan, S. V.; Davis, S. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1b/2, open-label dose-escalation and -expansion study evaluating trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with HER2+ and HER2-low gastric cancer (GC): DESTINY-Gastric03 (DG-03)
    Meeting Abstract

    Janjigian, Y. Y.; Raoufmoghaddam, S.; Sztachelska, M.; Winter, M.; Das, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save